Gansu Changee Bio-Pharmaceutical Co., Ltd.

Gansu ChanGee Bio-Pharmaceutical Co. Ltd is a high-tech and comprehensive enterprise integrating medicine, medical apparatus and instruments R&D, production and sales. As subsidiary of Hybio Pharmaceutical Co., Ltd. It is a double-certificate enterprise with "Drug production license" and "Medical device production license", with registered capital 229 million Yuan, 67 patents, and occupying an area of 117 acres.ChanGee specializes in pen-type injectors (insulin pen, disposable insulin pen), provides targeted development business of drug delivery system specialized in all kinds of biopharmaceuticals, gene pharmaceuticals for companies in the injection pen manufacturing industry. Products including pen-type insulin injector, pre-filled injector, automatic injector, pre-sealed injector, electronic injector and etc, are widely used in Liraglutide, Exenatide and other peptides, insulin glargine, insulin aspartate and other insulin preparations, auxin, interferon and other biological agents. Up to present, we have long-term cooperation with a number of pharmaceutical companies.ChanGee provides professional one-stop services on pen-type injector design, mold development, injection molding, finished product assembly and etc. To ensure products developed in high-difficulty and high-precision technology direction, ChanGee not only use precision computer injection molding machine, foreign precision measuring instruments and advanced mold CNC manufacturing equipment, but also own strong technical force to independently complete precision plastic mold manufacturing.